JOSEPH LAVALLO: Open Payments
NPI 1871720003 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 13 payments from 7 companies in 2025. Trend: 2023 $528 · 2024 $521 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $121 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $74 |
| JAZZ PHARMACEUTICALS INC. | 1 | $40 |
| Gilead Sciences, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Amgen Inc. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
Products named: DATROWAY, LifeVest, ZEPZELCA, Trodelvy, KEYTRUDA, MONJUVI.
Industry payments across GA — which companies pay providers there.
